Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Non-small Cell Lung Cancer
Clinical trial register · China

Non-small Cell Lung Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 07 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Changsha 16
Narrow the registerReset
Recruitment status
Phase
Site location
Changsha16
All 1 locations
Target enrolment
to

Non-small Cell Lung Cancer trials in China

16 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
NCT07001995Small Cell Lung Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer NSCLC
Hunan Province Tumor Hospital
Phase 2
30
Changsha
2026-05-01
Not yet open
Hunan Province Tumor Hospital
Phase 3
94
Changsha
2025-05-01
Not yet open
Hunan Province Tumor Hospital
Phase 2
30
Changsha
2024-11-30
Not yet open
Hunan Province Tumor Hospital
Phase 2
39
Changsha
2024-09-15
Recruiting
Hunan Province Tumor Hospital
Phase 2
52
Changsha
2024-07-01
Recruiting
Hunan Province Tumor Hospital
Phase 2
100
Changsha
2024-07-01
Recruiting
Hunan Province Tumor Hospital
Phase 2
220
Changsha
2024-05-01
Recruiting
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
NCT06109558Non Small Cell Lung Cancer, RET Gene Mutation, MET Amplification, EGF-R Positive Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 1/2
120
Changsha
2023-12-31
Recruiting
Hunan Province Tumor Hospital
Phase 2
140
Changsha
2022-12-25
Recruiting
Hunan Province Tumor Hospital
Phase 2
760
Changsha
2022-04-01
Recruiting
Hunan Province Tumor Hospital
Phase 2
90
Changsha
2021-11-13
Recruiting
Hunan Province Tumor Hospital
Observational
15,000
Changsha
2021-10-03
Recruiting
Hunan Province Tumor Hospital
Phase 2
120
Changsha
2021-08-01
Recruiting
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
NCT04322890Non Small Cell Lung Cancer, EGFR Gene Mutation, ALK Gene Mutation, ROS1 Gene Mutation
Hunan Province Tumor Hospital
Phase 2
6,000
Changsha
2020-04-16
Recruiting
Hunan Province Tumor Hospital
Observational
800
Changsha
2020-03-24
Recruiting
Hunan Province Tumor Hospital
Phase 2/3
1,200
Changsha
2020-03-24
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 7 November 2026. https://priyalifescience.com/clinical-trials-china/condition/non-small-cell-lung-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 07 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies listing the condition Non-small Cell Lung Cancer that also match the filters currently applied.

How many Non-small Cell Lung Cancer trials are recruiting in China?

12 of the 16 studies on this page are recruiting new participants as of the 07 Nov 2026, 03:17 UTC sync. A further 4 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Non-small Cell Lung Cancer), 16 studies
PhaseStudiesRecruitingShare
Phase 211868.8%
Observational2212.5%
Phase 1/2116.3%
Phase 2/3116.3%
Phase 3106.3%

Most active sponsors

Lead sponsors with the most studies (Non-small Cell Lung Cancer)
Lead sponsorStudiesRecruiting
Hunan Province Tumor Hospital1612
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.